Kiniksa Pharmaceuticals
KNSA
KNSA
96 hedge funds and large institutions have $539M invested in Kiniksa Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 48 increasing their positions, 14 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
23% more call options, than puts
Call options by funds: $1.04M | Put options by funds: $848K
2.55% less ownership
Funds ownership: 86.76% → 84.21% (-2.6%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
96
Holding in Top 10
–
Calls
$1.04M
Puts
$848K
Top Buyers
| 1 | +$21.3M | |
| 2 | +$15.4M | |
| 3 | +$14M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$13.1M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
+$10M |
Top Sellers
| 1 | -$19.7M | |
| 2 | -$8.42M | |
| 3 | -$2.88M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$1.6M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$1.15M |